OLMA – olema pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium [Yahoo! Finance]
Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium
Olema Oncology Announces FDA Clearance of Investigational New Drug Application for OP-3136, a Potent KAT6 Inhibitor
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Form 4/A Olema Pharmaceuticals, For: Dec 13 Filed by: Graham G. Walmsley
Form 4 Olema Pharmaceuticals, For: Dec 13 Filed by: Graham G. Walmsley
Form 4 Olema Pharmaceuticals, For: Dec 16 Filed by: Zojwalla Naseem
Form 144 Olema Pharmaceuticals, Filed by: Logos Opportunities Fund I LP
Form D Olema Pharmaceuticals,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.